Early research (Phase 1)Study completedNCT01738867
What this trial is testing
To Evaluate the Influence of the A118G Polymorphism in the mu Opioid Receptor Gene (OPRM1) on Effects of GSK1521498 and Naltrexone on Physiological and Behavioural Markers of Brain Function in Healthy Social Drinkers
Who this might be right for
Alcoholism
GlaxoSmithKline 56